Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic models

References

• Labrijn AF, Janmaat ML, Reichert JM, Parren P. Bispecific antibodies: A mechanistic review of the pipeline. Nat Rev Drug Discov. 2019;18(8):585–12. doi:https://doi.org/10.1038/s41573-019-0028-1.
   PubMed Web of Science ®Google Scholar
• Milstein C, Cuello AC. Hybrid hybridomas and their use in immunohistochemistry. Nature. 1983;305(5934):537–40. doi:https://doi.org/10.1038/305537a0.
   PubMed Web of Science ®Google Scholar
• Lindhofer H, Mocikat R, Steipe B, Thierfelder S. Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas. Implications for a single-step purification of bispecific antibodies. J Immunol. 1995;155:219–25.
   PubMed Web of Science ®Google Scholar
• Merchant AM, Zhu Z, Yuan JQ, Goddard A, Adams CW, Presta LG, Carter P. An efficient route to human bispecific IgG. Nat Biotechnol. 1998;16(7):677–81. doi:https://doi.org/10.1038/nbt0798-677.
   PubMed Web of Science ®Google Scholar
• Davis JH, Aperlo C, Li Y, Kurosawa E, Lan Y, Lo KM, Huston JS. Seedbodies: fusion proteins based on strand-exchange engineered domain (seed) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies. Protein Eng Des Sel. 2010;23(4):195–202. doi:https://doi.org/10.1093/protein/gzp094.
   PubMed Web of Science ®Google Scholar
• Gunasekaran K, Pentony M, Shen M, Garrett L, Forte C, Woodward A, Ng SB, Born T, Retter M, Manchulenko K, et al. Enhancing antibody Fc heterodimer formation through electrostatic steering effects: applications to bispecific molecules and monovalent IgG. J Biol Chem. 2010;285(25):19637–46. doi:https://doi.org/10.1074/jbc.M110.117382.
   PubMed Web of Science ®Google Scholar
• Strop P, Ho WH, Boustany LM, Abdiche YN, Lindquist KC, Farias SE, Rickert M, Appah CT, Pascua E, Radcliffe T, et al. Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair. J Mol Biol. 2012;420(3):204–19. doi:https://doi.org/10.1016/j.jmb.2012.04.020.
   PubMed Web of Science ®Google Scholar
• Schaefer W, Regula JT, Bahner M, Schanzer J, Croasdale R, Durr H, Gassner C, Georges G, Kettenberger H, Imhof-Jung S, et al. Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies. Proc Natl Acad Sci U S A. 2011;108(27):11187–92. doi:https://doi.org/10.1073/pnas.1019002108.
   PubMed Web of Science ®Google Scholar
• Von Kreudenstein TS, Escobar-Carbrera E, Lario PI, D’Angelo I, Brault K, Kelly J, Durocher Y, Baardsnes J, Woods RJ, Xie MH, et al. Improving biophysical properties of a bispecific antibody scaffold to aid developability: quality by molecular design. MAbs. 2013;5(5):646–54. doi:https://doi.org/10.4161/mabs.25632.
   PubMed Web of Science ®Google Scholar
• Mazor Y, Oganesyan V, Yang C, Hansen A, Wang J, Liu H, Sachsenmeier K, Carlson M, Gadre DV, Borrok MJ, et al. Improving target cell specificity using a novel monovalent bispecific IgG design. MAbs. 2015;7(2):377–89. doi:https://doi.org/10.1080/19420862.2015.1007816.
   PubMed Web of Science ®Google Scholar
• Labrijn AF, Meesters JI, de Goeij BE, van den Bremer ET, Neijssen J, van Kampen MD, Strumane K, Verploegen S, Kundu A, Gramer MJ, et al. Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange. Proc Natl Acad Sci U S A. 2013;110(13):5145–50. doi:https://doi.org/10.1073/pnas.1220145110.
   PubMed Web of Science ®Google Scholar
• Brinkmann U, Kontermann RE. The making of bispecific antibodies. MAbs. 2017;9(2):182–212. doi:https://doi.org/10.1080/19420862.2016.1268307.
   PubMed Web of Science ®Google Scholar
• Labrijn AF, Meesters JI, Bunce M, Armstrong AA, Somani S, Nesspor TC, Chiu ML, Altintas I, Verploegen S, Schuurman J, et al. Efficient generation of bispecific murine antibodies for pre-clinical investigations in syngeneic rodent models. Sci Rep. 2017;7(1):2476. doi:https://doi.org/10.1038/s41598-017-02823-9.
   PubMedGoogle Scholar
• Benonisson H, Altintas I, Sluijter M, Verploegen S, Labrijn AF, Schuurhuis DH, Houtkamp MA, Verbeek JS, Schuurman J, van Hall T. CD3-bispecific antibody therapy turns solid tumors into inflammatory sites but does not install protective memory. Mol Cancer Ther. 2019;18(2):312–22. doi:https://doi.org/10.1158/1535-7163.MCT-18-0679.
   PubMed Web of Science ®Google Scholar
• Keeble AH, Khan Z, Forster A, James LC. TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved. Proc Natl Acad Sci U S A. 2008;105(16):6045–50. doi:https://doi.org/10.1073/pnas.0800159105.
   PubMed Web of Science ®Google Scholar
• Clynes RA, Towers TL, Presta LG, Ravetch JV. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nature Medicine. 2000;6(4):443–46. doi:https://doi.org/10.1038/74704.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV. Fcgammariv: A novel FcR with distinct IgG subclass specificity. Immunity. 2005;23(1):41–51. doi:https://doi.org/10.1016/j.immuni.2005.05.010.
   PubMed Web of Science ®Google Scholar
• Baudino L, Shinohara Y, Nimmerjahn F, Furukawa J, Nakata M, Martinez-Soria E, Petry F, Ravetch JV, Nishimura S, Izui S. Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions. J Immunol. 2008;181(9):6664–69. doi:https://doi.org/10.4049/jimmunol.181.9.6664.
   PubMed Web of Science ®Google Scholar
• Harris LJ, Larson SB, Hasel KW, McPherson A. Refined structure of an intact IgG2a monoclonal antibody. Biochemistry. 1997;36:1581–97.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy A, Jimeno A. Bispecific antibodies for cancer therapy: A review. Pharmacol Ther. 2018;185:122–34. doi:https://doi.org/10.1016/j.pharmthera.2017.12.002.
   PubMed Web of Science ®Google Scholar
• Loffler A, Kufer P, Lutterbuse R, Zettl F, Daniel PT, Schwenkenbecher JM, Riethmuller G, Dorken B, Bargou RC. A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes. Blood. 2000;95(6):2098–103. doi:https://doi.org/10.1182/blood.V95.6.2098.
   PubMed Web of Science ®Google Scholar
• Smith EJ, Olson K, Haber LJ, Varghese B, Duramad P, Tustian AD, Oyejide A, Kirshner JR, Canova L, Menon J, et al. A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys. Sci Rep. 2015;5:17943:1–12. doi:https://doi.org/10.1038/srep17943.
   Google Scholar
• Sun LL, Ellerman D, Mathieu M, Hristopoulos M, Chen X, Li Y, Yan X, Clark R, Reyes A, Stefanich E, et al. Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of b cell malignancies. Sci Transl Med. 2015;7(287):287ra270. doi:https://doi.org/10.1126/scitranslmed.aaa4802.
   Web of Science ®Google Scholar
• Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A. 1987;84(5):1374–78. doi:https://doi.org/10.1073/pnas.84.5.1374.
   PubMed Web of Science ®Google Scholar
• Alegre ML, Tso JY, Sattar HA, Smith J, Desalle F, Cole M, Bluestone JA. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity. J Immunol. 1995;155:1544–55.
   PubMed Web of Science ®Google Scholar
• (Dunn RJSD, CA, US), Mertsching, Elisabeth (San Diego, CA, US), Peach, Robert (San Diego, CA, US), Kehry, Marilyn R. (San Diego, CA, US). Anti-mouse CD20 antibodies and uses thereof. In: Anti-mouse CD20 antibodies and uses thereof. United States: Biogen Idec Inc; 2007. (Cambridge, MA, US).
   Google Scholar
• Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J. 2000;78(3):1606–19. doi:https://doi.org/10.1016/S0006-3495(00)76713-0.
   PubMed Web of Science ®Google Scholar
• Kabsch W. XDS Acta Crystallogr D Biol Crystallogr. 2010;66(Pt2):125–32. doi:https://doi.org/10.1107/S0907444909047337.
   Google Scholar
• Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, et al. Phenix: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 2):213–21. doi:https://doi.org/10.1107/S0907444909052925.
   PubMed Web of Science ®Google Scholar
• Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of coot. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 4):486–501. doi:https://doi.org/10.1107/S0907444910007493.
   PubMed Web of Science ®Google Scholar
• Shaner NC, Lambert GG, Chammas A, Ni Y, Cranfill PJ, Baird MA, Sell BR, Allen JR, Day RN, Israelsson M, et al. A bright monomeric green fluorescent protein derived from branchiostoma lanceolatum. Nat Methods. 2013;10(5):407–09. doi:https://doi.org/10.1038/nmeth.2413.
   PubMed Web of Science ®Google Scholar